Axial spondyloarthritis (axSpA) is a type of inflammatory arthritis that affects the spinal joints and the joints that connect the bottom of the spine to the hip bones (the sacroiliac joints). Experts ...

Outpatient data show 13.90% radiographic hip involvement in axial spondyloarthritis, linked to longer duration and higher disease severity.

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% ...

Atul A. Deodhar, MD: Axial spondyloarthritis is an umbrella term that includes nonradiographic axial spondyloarthritis and ankylosing spondylitis. There is a lot of confusion about this term. In ...

MoonLake Immunotherapeutics MLTX shares are up during Monday’s premarket session following the announcement of positive topline results from its Phase 2 clinical trial of sonelokimab in treating axial ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) used its Investor Day presentation to outline updates across its clinical portfolio ...

Atul A. Deodhar, MD: The use of opioids is quite common in this population, mainly because back pain is so common in this population. Depending on which survey you look at, 30% to 40% of the patients ...

Patients with axSpA can wait 10 years after symptom onset to be diagnosed with the condition. There are currently no guidelines to advise clinicians on when to refer to a rheumatologist, and with the ...

Please provide your email address to receive an email when new articles are posted on . Acute anterior uveitis in first-degree relatives of axial spondyloarthritis ...

Please provide your email address to receive an email when new articles are posted on . Among patients diagnosed with definite axial SpA at baseline, 94% retained the diagnosis 2 years later. Features ...

Patients with axial psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) plus psoriasis differ with respect to clinical and genetic characteristics, according to the findings of a recent ...